Friday, March 06, 2026 10:56:35 AM
IMUX...........................https://stockcharts.com/sc3/ui/?s=IMUX&p=w&b=5&g=0&id=p86431144783
Recent IMUX News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:34:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 11:01:04 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 10:36:56 AM
- Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update • PR Newswire (US) • 05/13/2026 10:30:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/06/2026 10:01:51 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 04/30/2026 09:15:46 PM
- Immunic to Participate in Investor and Medical Conferences in May • PR Newswire (US) • 04/30/2026 10:30:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/29/2026 11:12:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 11:00:28 AM
- Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer • PR Newswire (US) • 04/28/2026 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2026 12:30:43 PM
- Immunic, Inc. Announces 1-for-10 Reverse Stock Split • PR Newswire (US) • 04/23/2026 12:00:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/22/2026 08:56:18 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/17/2026 02:13:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/14/2026 08:05:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:05:25 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 04/09/2026 08:30:55 PM
- Immunic to Participate in Scientific and Medical Conferences in April • PR Newswire (US) • 04/09/2026 10:30:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/02/2026 08:31:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 11:00:32 AM
- Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement • PR Newswire (US) • 04/01/2026 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 10:45:34 AM
